2.1. Study design and patient population
MAY
This study was approved by the institutional review board of the No.950 hospital (No: 2021ky003), and written informed consent was obtained from all participating patients. This study was conducted in the No.950 hospital from April 2021 to May 2022, accordance with the Declaration of Helsinki of 1975, as revised in 2013. This trial was registered with the Chinese Clinical Trial Registry (ChiCTR2200058941), and a total of 118 patients were recruited. Trial reporting was in alignment with the consolidated standards of reporting trials 2010 guidelines.The inclusion criteria were the following: adult women scheduled for open hysterectomy with CSEA; aged 35~75 years; body mass index (BMI) ≥ 30 kg/mCONSORT flow diagram. CONSORT = consolidated standards of reporting trials.